The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women With Advanced Breast Cancer

King Faisal Specialist Hospital & Research Center2 enrolled

Overview

The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women with Advanced Breast Cancer A Prospective Trial.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Advanced Breast Cancer

Interventions

GnRh Analogue and Aromatase InhibitorOTHER

GnRh Analogue and Aromatase Inhibitor

Eligibility

Sex: FEMALEMin age: 45 YearsMax age: 85 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Receptor Positive Premenopausal Women with Advanced Breast Cancer. Exclusion Criteria: * Any woman other than diagnosis of Receptor Positive Premenopausal with Advanced Breast Cancer.

Locations (1)

Kfsh & Rc

Riyadh, Saudi Arabia

RECRUITING

Central Contacts

Al Sayed, M.D.

CONTACT

+966-1-4423949

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.